| Wanbury Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524212 |
NSE Symbol : WANBURY |
P/E(TTM) : 33.91 |
|
ISIN Demat : INE107F01022 |
Div & Yield% : - |
EPS(TTM) : 8.36 |
|
Book Value(₹) : 11.83 |
Market Cap(₹Cr) : 929.04 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|
| Gross Sales | 161.19 | 131.11 | 139.41 | 145.50 | 144.46 | 146.29 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 161.19 | 131.11 | 139.41 | 145.50 | 144.46 | 146.29 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.63 | 0.94 | 0.93 | 0.69 | 0.76 | 0.62 |
| Total Income | 162.82 | 132.05 | 140.33 | 146.19 | 145.22 | 146.90 |
| Total Expenditure | 141.18 | 120.13 | 121.24 | 124.35 | 127.12 | 132.94 |
| PBIDT | 21.64 | 11.92 | 19.09 | 21.84 | 18.10 | 13.96 |
| Interest | 10.15 | 7.59 | 7.46 | 8.26 | 7.67 | 5.79 |
| PBDT | 11.49 | 4.33 | 11.63 | 13.58 | 10.43 | 8.18 |
| Depreciation | 3.32 | 3.29 | 3.28 | 3.32 | 3.24 | 3.18 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.15 | 0.00 | 0.27 | -0.02 | -0.18 | 0.30 |
| Reported Profit After Tax | 8.02 | 1.04 | 8.08 | 10.27 | 7.36 | 4.69 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 8.02 | 1.04 | 8.08 | 10.27 | 7.36 | 4.69 |
| EPS (Unit Curr.) | 2.44 | 0.32 | 2.47 | 3.14 | 2.25 | 1.43 |
| EPS (Adj) (Unit Curr.) | 2.44 | 0.32 | 2.47 | 3.14 | 2.25 | 1.43 |
| Calculated EPS (Unit Curr.) | 2.45 | 0.32 | 2.47 | 3.14 | 2.25 | 1.43 |
| Calculated EPS (Adj) (Unit Curr.) | 2.45 | 0.32 | 2.47 | 3.14 | 2.25 | 1.43 |
| Calculated EPS (Ann.) (Unit Curr.) | 9.79 | 1.27 | 9.87 | 12.55 | 9.00 | 5.73 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 9.79 | 1.27 | 9.87 | 12.55 | 9.00 | 5.73 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 32.76 | 32.75 | 32.75 | 32.75 | 32.74 | 32.71 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 13.43 | 9.09 | 13.69 | 15.01 | 12.53 | 9.54 |
| PBDTM(%) | 7.13 | 3.30 | 8.34 | 9.33 | 7.22 | 5.59 |
| PATM(%) | 4.98 | 0.79 | 5.80 | 7.06 | 5.09 | 3.21 |